We are live on
!
Find out more
BCPEM
Bain Capital Public Equity Management Portfolio holdings
AUM
$1.05B
1-Year Est. Return
25.71%
This Fund
S&P 500
This Quarter
Est. Return
+2.65%
1 Year Est. Return
+25.71%
3 Year Est. Return
+127.65%
5 Year Est. Return
+213.44%
10 Year Est. Return
–
AUM
$1.47B
AUM Growth
-$68.6M
(-4.5%)
Cap. Flow
-$43.1M
Cap. Flow
% of AUM
-2.92%
Top 10 Holdings %
Top 10 Hldgs %
49.21%
Holding
67
New
36
Increased
4
Reduced
14
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$97.8M |
| 2 |
LLL
L3 Technologies, Inc.
LLL
|
+$93.7M |
| 3 |
Hilton Worldwide
HLT
|
+$84M |
| 4 |
Comcast
CMCSA
|
+$60.7M |
| 5 |
Johnson Controls International
JCI
|
+$58.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$124M |
| 2 |
DATA
Tableau Software, Inc.
DATA
|
+$91.2M |
| 3 |
AGN
Allergan plc
AGN
|
+$84.2M |
| 4 |
Fidelity National Information Services
FIS
|
+$78.1M |
| 5 |
Sabre
SABR
|
+$56.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.07% |
| 2 | Industrials | 20.82% |
| 3 | Healthcare | 20.56% |
| 4 | Consumer Discretionary | 15% |
| 5 | Communication Services | 6.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
CALL
Merck
MRK
$355B
| $20.5M | 1.39% |
52,400
+41,040
| +361% | +$2.4M |
|
|
MGP
27
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $19.9M | 1.35% |
787,974
-272,728
| -26% | -$6.8M |
|
28
Voyager Therapeutics
VYGR
$190M
| $19.3M | 1.31% |
1,514,082
| – | – |
|
|
EVHC
29
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $18.9M | 1.28% |
+298,056
| New | +$19.5M |
|
|
AET
30
DELISTED
Aetna Inc
AET
| $16.4M | 1.11% |
+132,318
| New | +$15.8M |
|
|
ONCE
31
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $16.4M | 1.11% |
328,113
-39,201
| -11% | -$2.1M |
|
32
Hubbell
HUBB
$23.2B
| $15.3M | 1.04% |
+131,536
| New | +$14.5M |
|
33
SBA Communications
SBAC
$19.4B
| $11.7M | 0.79% |
113,093
-28,493
| -20% | -$3M |
|
|
KATE
34
DELISTED
Kate Spade & Company
KATE
| $11M | 0.75% |
+588,078
| New | +$9.64M |
|
35
Northrop Grumman
NOC
$75.5B
| $10.4M | 0.7% |
+44,600
| New | +$10.4M |
|
36
Global Payments
GPN
$23.5B
| $10.2M | 0.69% |
+147,099
| New | +$10.6M |
|
37
Norfolk Southern
NSC
$71.9B
| $9.99M | 0.68% |
+92,400
| New | +$9.33M |
|
38
Fortive
FTV
$17B
| $9.89M | 0.67% |
+292,336
| New | +$9.67M |
|
39
GoDaddy
GDDY
$13B
| $9.74M | 0.66% |
+278,800
| New | +$9.78M |
|
40
Lennox International
LII
$12.5B
| $9.57M | 0.65% |
+62,500
| New | +$9.55M |
|
41
Crown Castle
CCI
$31.2B
| $8.17M | 0.55% |
94,107
-68,327
| -42% | -$5.98M |
|
42
ON Semiconductor
ON
$28.5B
| $5.38M | 0.37% |
+422,000
| New | +$5.04M |
|
43
CALL
AstraZeneca
AZN
$251B
| $4.9M | 0.33% |
+20,000
| New | +$1.14M |
|
44
Synchrony
SYF
$24.7B
| $4.89M | 0.33% |
+134,800
| New | +$4.3M |
|
45
Televisa
TV
$1.19B
| $4.66M | 0.32% |
223,223
-1,448,403
| -87% | -$33.3M |
|
|
DATA
46
CALL
DELISTED
Tableau Software, Inc.
DATA
| $4.47M | 0.3% |
+7,500
| New | +$349K |
|
47
Teleflex
TFX
$5.47B
| $4.16M | 0.28% |
25,800
-134,791
| -84% | -$21M |
|
48
Sprouts Farmers Market
SFM
$6.85B
| $3.8M | 0.26% |
+200,740
| New | +$4.22M |
|
|
AFMD
49
DELISTED
Affimed
AFMD
| $3.78M | 0.26% |
209,790
| – | – |
|
50
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$799B
| $2.97M | 0.2% |
+6,600
| New | +$1.44M |
|
Similar funds
WF
DCM
AB
MFBTD
IAS
SA
TL
ACM
Bain Capital Public Equity Management's Q4 2016 Portfolio in Review
As of Q4 2016, Bain Capital Public Equity Management held 67 positions worth $1.47B, down 4.5% from $1.54B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Bain Capital Public Equity Management's Q4 2016 filing shows 36 new, 4 increased, 14 reduced and 10 closed positions. Its largest new stake was General Dynamics: 597,904 shares worth $103M. The largest sale was Merck, an estimated $124M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 42% a quarter earlier, followed by Industrials and Healthcare.
- Bain Capital Public Equity Management's largest Q4 2016 buy was General Dynamics: 597,904 shares worth $103M.
- Bain Capital Public Equity Management added most to ARRIS International plc Ordinary Shares in Q4 2016, an estimated $11.5M increase.
- Bain Capital Public Equity Management's biggest Q4 2016 reduction was Allergan plc, cutting an estimated $84.2M.
- Bain Capital Public Equity Management fully exited Merck in Q4 2016, selling an estimated $124M.
- Bain Capital Public Equity Management's ten largest holdings make up 49% of its $1.47B portfolio in Q4 2016.
- Bain Capital Public Equity Management opened 36 new positions and closed 10 in Q4 2016.
- Bain Capital Public Equity Management's portfolio value fell 4.5% quarter-over-quarter to $1.47B.
Based on Bain Capital Public Equity Management's 13F filing for Q4 2016, filed 14 Feb 2017.